𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗽𝗼𝘄𝗲𝗿 𝗼𝗳 𝗪𝗢𝟲! With an elegant texture that’s ideal for dermatological and cosmetic preparations, this anhydrous topical gel accommodates APIs that are unstable in aqueous environments and allows for the potential for longer beyond-use dates.* *USP 795 establishes BUD limits by type of preparation in the absence of a USP−NF Compounded Preparation Monograph or CNSP-specific stability information. Learn more 👉 https://bit.ly/4esAq1e
PCCA’s Post
More Relevant Posts
-
July has rolled in, and summer is calling! ☀️🏖️ Get ready for sun, fun and the latest compounding updates on #ThePCCABlog. ☑️ Biohacking: Explained ☑️ Potential Options for Migraine Patients ☑️ Acne Patients: You’re Not Alone Keep expanding your industry knowledge 👉 https://lnkd.in/gSxhHAm5
To view or add a comment, sign in
-
Are you interested in discovering how we can enhance your pharmacy's success? Join us at the PTEC 2024 Conference on July 11-12. Stop by our booth to meet Erin, who will give you all the details about PCCA membership, such as: ☑️ Tailored solutions for your pharmacy ☑️ Comprehensive support ☑️ Best-in-class education Come see how we can make a difference for your pharmacy! Pharmacy Technician Educators Council (PTEC) #PTEC2024
To view or add a comment, sign in
-
-
⌛ Time's running out! Sign up for our USP Implementation Training today 👉 https://bit.ly/USP-24
USP Implementation Training
To view or add a comment, sign in
-
🎙️ Did you miss our latest episode of Tech Talk? Join the conversation with Adrianna Rodriguez, Director of Operations and Sales at Stone Oak Pharmacy, as she shares her fascinating journey in compounding. Adrianna discusses her continuous pursuit of knowledge and the central role networking plays in their operations, which they leverage to learn best practices and innovate processes to enhance their approach and drive improvements at their pharmacy. 🎧 Listen to the full episode of #TheMortarAndPestlePodcast for insights that can inspire your professional development 👉 https://bit.ly/3L2XVQT
The Mortar & Pestle Podcast | Tech Talk: An Interview with Adrianna Rodriguez
To view or add a comment, sign in
-
Explore a world of customized solutions and exceptional service! 🌟 Our white glove experience guarantees precision in meeting your eLearning needs, making your journey unforgettable. See what our members are saying! Learn more 👉 https://bit.ly/4blljUc
eLearning Compounding Training
To view or add a comment, sign in
-
Thank you to our team and to our members for making McKesson ideaShare a memorable event! It was a pleasure to connect face-to-face, discuss innovations in personalized medicine and network with top professionals. We hope you grabbed a pair of rockstar socks! 🤟🧦 #McKessonideaShare2024
-
-
-
-
-
+1
To view or add a comment, sign in
-
-
Exciting news! Our February 2024 HRT Symposium in Las Vegas was such a hit, we're bringing back the speakers for a LIVE, VIRTUAL edition! ✨ Join us for expert insights on weight loss, menopause, microbiome, insulin resistance, thyroid, adrenals, detox and more — all from the comfort of home. Perfect for practitioners and pharmacists, this symposium offers evidence-based HRT info focusing on causes, not just symptoms. Whether new to HRT or seeking the latest in personalized medicine, this is for you! Register today 👉 https://lnkd.in/gkjWBmPX
To view or add a comment, sign in
-
-
Discover the latest in skincare at our Dermatology One-Day Virtual Conference on August 13! From clinical dermatology to cosmeceuticals and anti-aging solutions, we've got you covered. Learn about common compounds, master tips for tricky ingredients and explore the hottest skincare formulas. Pharmacists & technicians who complete C4 Derm by June 28 can earn a Dermatology Specialist designation by attending this event. 📚 Secure your spot today 👉 https://bit.ly/Derm24 #Dermatology #VirtualConference
To view or add a comment, sign in
-
-
The moment has arrived: Our team is here at McKesson ideaShare! Come visit us at booth #308 to learn how we can help your pharmacy thrive! 🌟 #McKessonideaShare2024
To view or add a comment, sign in